Umeshita K - Search Results

1

Effects of preceding interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma.

Tomimaru Y, Nagano H, Eguchi H, Kobayashi S, Marubashi S, Wada H, Tanemura M, Umeshita K, Hiramatsu N, Takehara T, Doki Y, Mori M. Tomimaru Y, et al. Among authors: umeshita k. J Surg Oncol. 2010 Sep 15;102(4):308-14. doi: 10.1002/jso.21633. J Surg Oncol. 2010. PMID: 20589711

2

[The relationship between postoperative prognosis and positivity of PIVKA-II in patients with hepatocellular carcinoma].

Sakon M, Monden M, Goto M, Kanai T, Umeshita K, Ukei T, Mori T. Sakon M, et al. Among authors: umeshita k. Nihon Geka Gakkai Zasshi. 1992 Aug;93(8):827-32. Nihon Geka Gakkai Zasshi. 1992. PMID: 1331743 Japanese.

3

Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions.

Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang KS, Sakurai M, Kuroda C, Okamura J, Mori T. Monden M, et al. Among authors: umeshita k. Cancer Chemother Pharmacol. 1992;31 Suppl:S38-44. doi: 10.1007/BF00687103. Cancer Chemother Pharmacol. 1992. PMID: 1333907

4

Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.

Fukuzaki T, Gotoh M, Hasuike Y, Tanigawa T, Nagano H, Umeshita K, Kanai T, Monden M, Mori T. Fukuzaki T, et al. Among authors: umeshita k. Transplant Proc. 1994 Apr;26(2):779. Transplant Proc. 1994. PMID: 7513472 No abstract available.

5

The prognostic significance of macroscopic growth pattern of hepatocellular carcinoma.

Sakon M, Monden M, Umeshita K, Gotoh M, Kanai T, Mori T, Okamura J. Sakon M, et al. Among authors: umeshita k. Int Surg. 1994 Jan-Mar;79(1):38-42. Int Surg. 1994. PMID: 8063553

6

New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases.

Kanai T, Monden M, Sakon M, Gotoh M, Umeshita K, Hasuike Y, Nakano H, Monden T, Murakami T, Nakamura H, et al. Kanai T, et al. Among authors: umeshita k. Cancer Chemother Pharmacol. 1994;33 Suppl:S48-54. doi: 10.1007/BF00686668. Cancer Chemother Pharmacol. 1994. PMID: 8137485

7

Hilar lobar vascular occlusion for hepatic resection.

Gotoh M, Monden M, Sakon M, Kanai T, Umeshita K, Nagano H, Mori T. Gotoh M, et al. Among authors: umeshita k. J Am Coll Surg. 1994 Jan;178(1):6-10. J Am Coll Surg. 1994. PMID: 8156120

8

Fatal differentiated thyroid cancer.

Kobayashi T, Asakawa H, Tamaki Y, Umeshita K, Monden M. Kobayashi T, et al. Among authors: umeshita k. J Surg Oncol. 1996 Jun;62(2):123-7. doi: 10.1002/(SICI)1096-9098(199606)62:2<123::AID-JSO8>3.0.CO;2-A. J Surg Oncol. 1996. PMID: 8649038

9

[Borderline lesions of adenomatous hyperplasia and hepatocellular carcinoma].

Sakon M, Kanai T, Umeshita K, Hasuike Y, Gotoh M, Monden M, Wakasa K, Sakurai M. Sakon M, et al. Among authors: umeshita k. Ryoikibetsu Shokogun Shirizu. 1995;(7):441-5. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749520 Review. Japanese. No abstract available.

10

[Well-differentiated hepatocellular carcinoma].

Umeshita K, Sakon M, Hasuike Y, Kanai T, Gotoh M, Monden M, Wakasa K, Sakurai M. Umeshita K, et al. Ryoikibetsu Shokogun Shirizu. 1995;(7):470-2. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749528 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters